TLX shares rise about 5% ahead of FDA decision next Friday
NASDAQ-listed Telix Pharmaceuticals (TLX) climbed for the week as investors focused on a U.S. FDA decision due next Friday on its brain-cancer imaging agent. TLX traded around $11.90 on Friday.